AVENUE THERAPEUTICS, INC. Uncategorized Contracts & Agreements

17 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
At the Market Offering Agreement between Avenue Therapeutics, Inc. and H.C. Wainwright & Co., LLC dated May 10, 2024
Equity Distribution Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2024
Avenue Therapeutics Inducement Offer and Warrant Exercise Agreement with Holder
Warrant Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
2024
Description of Securities Registered Under Section 12 – Avenue Therapeutics, Inc.
Stock Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2024
Avenue Therapeutics Inducement Offer to Exercise Common Stock Purchase Warrants Agreement (January 2024)
Warrant Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
2024
Avenue Therapeutics Inducement Offer to Exercise Common Stock Purchase Warrants Agreement (January 2024)
Warrant Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
2024
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 by Avenue Therapeutics, Inc.
Equity Distribution Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2023
Placement Agent Agreement between Avenue Therapeutics, Inc. and Aegis Capital Corp. (January 27, 2023)
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2023
Avenue Therapeutics, Inc. Lock-Up Agreement Dated January 27, 2023
Waiver Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
2023
Description of ATXI Capital Stock, Warrants, and Debt Securities Registered Under Section 12 of the Exchange Act
Stock Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2022
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 by Avenue Therapeutics, Inc.
Equity Distribution Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2021
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 by Avenue Therapeutics, Inc.
Equity Distribution Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2020
Contingent Value Rights Agreement between Avenue Therapeutics, Inc. and Rights Agent
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
DE
2019
Restrictive Covenant Agreement between InvaGen Pharmaceuticals Inc. and Lucy Lu, M.D.
Non-Competition Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
DE
2018
Fortress Restrictive Covenant Agreement between InvaGen Pharmaceuticals Inc. and Fortress Biotech, Inc. (November 12, 2018)
Non-Competition Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
2018
Stockholders Agreement among InvaGen Pharmaceuticals Inc., Avenue Therapeutics, Inc., and Certain Stockholders (November 12, 2018)
Shareholders Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
DE
2018
Avenue Therapeutics, Inc. Employment Offer Letter to Joseph W. Vazzano, CPA (June 28, 2017)
Employment Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
2017
Second Amendment to Asset Transfer and License Agreement between Revogenex Ireland Limited and Fortress Biotech, Inc.
License Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
2017